To validate this, we performed a flow cytometry experiment of PMA/ionomycin-activated and unstimulated CD8+ TIL from endometrial cancer digests including these markers plus IFN-γ, TNF-α, and IL-2 as an internal control. The gene discussed is CD8A; the disease is endometrial cancer.